Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

BACKGROUND: The objective was to evaluate the safety, reactogenicity and immunogenicity of the AMA-1-based blood-stage malaria vaccine FMP2.1/AS02A in adults exposed to seasonal malaria. METHODOLOGY/PRINCIPAL FINDINGS: A phase 1 double blind randomized controlled dose escalation trial was conducted...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Thera, Mahamadou A., Doumbo, Ogobara K., Coulibaly, Drissa, Diallo, Dapa A., Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Dicko, Alassane, Sagara, Issaka, Sissoko, Mahamadou S., Baby, Mounirou, Sissoko, Mady, Diarra, Issa, Niangaly, Amadou, Dolo, Amagana, Daou, Modibo, Diawara, Sory I., Heppner, D. Gray, Stewart, V. Ann, Angov, Evelina, Bergmann-Leitner, Elke S., Lanar, David E., Dutta, Sheetij, Soisson, Lorraine, Diggs, Carter L., Leach, Amanda, Owusu, Alex, Dubois, Marie-Claude, Cohen, Joe, Nixon, Jason N., Gregson, Aric, Takala, Shannon L., Lyke, Kirsten E., Plowe, Christopher V.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2008
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2186380/
https://ncbi.nlm.nih.gov/pubmed/18213374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001465
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы